ArticlebioRxiv : the preprint server for biology2025
Precision targeting of C3+ reactive astrocyte subpopulations with endogenous ADAR in an iPSC-derived model.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Astrocytes play pivotal roles in maintaining neural architecture and function. However, their pronounced heterogeneity, especially in reactive states where distinct subtypes can adopt potentially opposing functions (e.g., neuroprotective vs. neuroinflammatory), complicates our understanding of their net contributions to neurological disorders. A critical challenge arises because these functionally distinct subpopulations often coexist, and the lack of precise tools to separately monitor or manipulate them has significantly hindered efforts to dissect their specific roles in disease progression. Here, we address this gap by developing and optimizing fluorescent RNA sensors mediated by endogenous adenosine deaminase acting on RNA (ADAR) for application in induced pluripotent stem cell (iPSC)-derived astrocytes. We employed a streamlined screening methodology to enhance sensor specificity and functionality for complement component 3 (C3), a key marker predominantly associated with neuroinflammatory astrocytes, thus enabling subtype-specific tracking and providing a crucial tool for distinguishing these cells within heterogeneous populations. By integrating the biological complexity of astrocytes with the technological precision of ADAR-mediated sensing, this study establishes a robust framework for investigating astrocyte dynamics.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.